Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs in rheumatoid arthritis: results of the GO-MORE study in Spain.
Reumatol Clin
; 11(3): 144-50, 2015.
Article
in En
| MEDLINE
| ID: mdl-25022442
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Methotrexate
/
Antirheumatic Agents
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Reumatol Clin
Year:
2015
Document type:
Article
Country of publication:
Spain